BRIEF-Aviragen Therapeutics announces results from phase 2 study

* Aviragen Therapeutics announces top-line results from phase 2A RSV challenge study of bta585 [Source]

Publication Date: Thursday, 2 February 2017 at 00:12:06

Origin: reuters.com

Category: rbssHealthcareNews

Topics: study, results, announces, Therapeutics, bta585, challenge, from phase, top-line, Aviragen, phase, BRIEF-Aviragen

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/Ha1tJwosRqc/idUSFWN1FM147

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22